Evidence map›Paper›PMID 22083825›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2012

High throughput profiling of serum phosphoproteins/peptides using the SELDI-TOF-MS platform.

Lin Ji, Gitanjali Jayachandran, Jack A Roth

Abstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
6.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Lin JiDepartment of Thoracic and Cardiovascular Surgery, The University of Texas, Anderson Cancer Center, Houston, TX, USA. lji@mdanderson.org
Gitanjali Jayachandran
Jack A Roth
The University of Texas MD Anderson Cancer Center · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
UNIVERSITY OF TEXAS--SPORE IN LUNG CANCERP50CA070907 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI GIBBONS, DON LYNN · 1996 to 2024
$57.4M
Modeling Airway Lung Cancer and the Role of InflammationU01CA105352 · NCI · BAYLOR COLLEGE OF MEDICINE · PI DEMAYO, FRANCESCO JOHN · 2004 to 2008
$4.2M
Tumor and PTK-Targeted Therapy by FUS1 and PTK inhibitorR01CA116322 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI JI, LIN · 2007 to 2010
$1.1M
NCI NIH HHS CA16672NCI NIH HHS P30 CA016672NCI NIH HHS P50 CA070907NCI NIH HHS P50CA070907NCI NIH HHS R01 CA116322NCI NIH HHS R01CA116322NCI NIH HHS U01 CA105352NCI NIH HHS U01CA105352
6 · The paper itself

Abstract

Protein phosphorylation is a dynamic post-translational modification that plays a critical role in the regulation of a wide spectrum of biological events and cellular functions including signal transduction, gene expression, cell proliferation, and apoptosis. Determination of the sites and magnitudes of protein phosphorylation has been an essential step in the analysis of the control of many biological systems. A high throughput analysis of phosphorylation of proteins would provide a simple, logical, and useful tool for a functional dissection and prediction of biological functions and signaling pathways in association with these important molecular events. We have developed a functional proteomics technique using the ProteinChip array-based SELDI-TOF-MS analysis for high throughput profiling of phosphoproteins/phosphopeptides in human serum for the early detection and diagnosis as well as for the molecular staging of human cancer. The methodology and experimental approach consists of five steps: (1) generation of a total peptide pool of serum proteins by a global trypsin digestion; (2) rapid isolation of phosphopeptides from the total serum peptide pool by an affinity selection, purification, and enrichment using a novel automated micro-bioprocessing system with phospho-antibody-conjugated paramagnetic beads and a hybrid magnet plate; (3) high throughput phosphopeptide analysis on ProteinChip arrays by automated SELDI-TOF-MS; and (4) bioinformatics and statistical methods for data analysis. This method with appropriate modifications may be equally applicable to serine-, threonine- and tyrosine-phosphorylated proteins and for selectively isolating, profiling, and identifying phosphopeptides present in a highly complex phosphor-peptide mixture prepared from various human specimens such as cells, tissue samples, and serum and other body fluids.

Indexed as

Analytic Sample Preparation MethodsAntibodiesHumansImmobilized ProteinsMagnetsMicrospheresPeptide HydrolasesPhosphopeptidesPhosphoproteinsProtein Array AnalysisProteolysisProteomicsSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationStatistics as TopicAntibodiesImmobilized ProteinsPeptide HydrolasesPhosphopeptidesPhosphoproteins

Identifiers

PMID22083825
PMCPMC3369544
OpenAlexW1622676647

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.